LENZ Therapeutics (LENZ) Short-term Investments (2020 - 2026)

LENZ Therapeutics (LENZ) has reported Short-term Investments for 7 consecutive years, with $233.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Short-term Investments rose 204823.68% year-over-year to $233.6 million; the TTM figure through Mar 2026 stood at $233.6 million (up 204823.68% YoY), while the FY2025 annual figure was $267.2 million, up 234257.89% from the prior year.
• Short-term Investments slipped to $233.6 million in Q1 2026 per LENZ's latest filing, from $267.2 million in the prior quarter.
• Across five years, Short-term Investments topped out at $267.2 million in Q4 2025 and bottomed at $100000.0 in Q1 2024.
• Historically, Short-term Investments has averaged $113.5 million across 5 years, with a median of $118.2 million in 2023.
• Annual changes were most pronounced in 2024 — Short-term Investments slumped 99.95% — and 2025, when it soared 234257.89%.
• LENZ Therapeutics' Short-term Investments stood at $220.5 million in 2022, then sank by 86.1% to $30.7 million in 2023, then sank by 99.63% to $114000.0 in 2024, then jumped by 234257.89% to $267.2 million in 2025, then retreated by 12.56% to $233.6 million in 2026.
• Business Quant data shows LENZ's Short-term Investments at $233.6 million in Q1 2026, $267.2 million in Q4 2025, and $176.8 million in Q3 2025.